Placebo control for new anthrax vaccine Cyfendus was The old anthrax vaccine

Now we have the label and the side effects are horrendous

You can’t make this stuff up. They call it a safety trial. Is this a label or a cartoon?

Here is all you need to know about this vaccine.

  1. It doesn’t work. You can’t be sprayed with anthrax and then get vaccinated and then patiently wait a month to develop immunity. You’d be dead by then. PLUS, if you lived, you would of course show immunity by a month because you were just exposed to anthrax!
  2. The FDA admits it does not work because you are required to take antibiotics with it—and it is the antibiotics that actually kill anthrax after an acute exposure.
  3. The side effects are awful. 64 percent had limited use of their arm after the shot. 84 percent had a systemic reaction. Eight percent of subjects refused the second shot.
  4. This shot is the old anthrax shot with a novel adjuvant added—so it cannot possibly be safer than the bad old vaccine.
  5. The old vaccine caused birth defects: “In the observational study there were more birth defects in infants born to individuals vaccinated with BioThrax in the first trimester compared to individuals vaccinated post pregnancy or individuals never vaccinated with BioThrax. Data from the BioThrax pregnancy exposure registry do not establish the presence or absence of vaccine-associated risks in pregnancy (see Human Data).”
  6. Cyfendus: “Of the 11 pregnancies (one twin pregnancy), 1 (9.1 percent) resulted in miscarriage and there were 2 infants (18.2 percent) born with major birth defects.”
  7. “CYFENDUS contains 100 mcg/mL total adsorbed cell-free filtrate, 1.3 mg/mL aluminum adjuvant, 0.5 mg/mL CPG 7909 [DNA] adjuvant, and 0.85 percent sodium chloride, with 25 mcg/mL benzethonium chloride and 100 mcg/mL formaldehyde added as preservatives.”
  8. “Logistic regression analysis demonstrated that a 70 percent probability of survival [8 wks after full dose] was associated with a TNA NF50 (50 percent neutralization factor) level of 0.56 in rabbits and 0.29 in NHPs.”—does not sound promising.

See more here substack.com

Header image: Children’s Health Defense

Please Donate Below To Support Our Ongoing Work To Defend The Scientific Method

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.

Comments (3)

  • Avatar

    VOWG

    |

    More poison, wow, we are advancing rapidly.

    Reply

  • Avatar

    Tom

    |

    This has been standard testing/trial procedure for many big pharma drugs for decades. If big pharma actually performed honest trials with true placebos and double blinding, their failure rate would put them out of business in a year or two.

    Reply

  • Avatar

    Carmel

    |

    ‘In the trials that led to the vaccines being approved in the UK, volunteers were randomly allocated to receive either the active vaccine or a control injection (some of which were a vaccine for MENINGITIS).’
    https://www.theguardian.com/commentisfree/2021/mar/15/evidence-oxford-vaccine-blood-clots-data-causal-links?

    ‘This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (MENINGOCOCCAL group A, C, W, and Y conjugate vaccine or saline).’
    https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext

    ‘Meningococcal conjugate vaccine contains four of the most common types of meningococcal bacteria (serogroups A, C, Y, and W-135).’

    ‘The Menactra brand of this vaccine should NOT BE given to anyone younger than 9 months or OLDER THAN 55 years of age. The Menveo brand should not be given to anyone younger than 2 months or OLDER THAN 65 years of age.’

    ‘Meningococcal conjugate vaccine is USUALLY ONLY GIVEN ONCE to adults and children who are 2 years and older. Younger children will need to receive 2 to 4 doses. You may need a booster dose if you have a high risk of meningococcal infection and it has been at least 4 years since you last received this vaccine.’
    ‘Get emergency medical help if you have signs of an allergic reaction:hives; dizziness, weakness; fast heartbeats; difficult breathing; swelling of your face, lips, tongue, or throat.’

    ‘You should not receive a booster vaccine if you had A LIFE THREATENING ALLERGIC REACTION after the first shot.’

    ‘You may feel faint after receiving this vaccine. Some people have had SEIZURE LIKE REACTIONS after receiving this vaccine.’

    ‘Before receiving this vaccine, tell your doctor about all other vaccines you have recently received,…’

    https://www.drugs.com/mtm/meningococcal-conjugate-vaccine.html#

    Reply

Leave a comment

Save my name, email, and website in this browser for the next time I comment.
Share via